Summary
Bristol-Myers Squibb Company (BMY) filed an 8-K on July 28, 2021, to report its financial results for the second quarter of 2021. The filing includes the earnings press release, supplemental financial information, and a presentation related to financial and operating initiatives. Investors should refer to these documents for detailed information on the company's performance and strategic updates during the quarter. The earnings press release and supplemental information are crucial for understanding BMY's operational and financial condition, including key performance indicators and any forward-looking statements. The accompanying presentation offers further insights into the company's strategies and financial discussions, providing a comprehensive view for investors seeking to assess the company's current standing and future prospects.
Key Highlights
- 1BMY announced its second quarter 2021 financial results on July 28, 2021, via an 8-K filing.
- 2The filing incorporates by reference the official Earnings Press Release (Exhibit 99.1) detailing Q2 2021 financial performance.
- 3Supplemental financial information (Exhibit 99.2) is also provided on the company's website and incorporated into the filing.
- 4A presentation (Exhibit 99.3) discussing financial and operating initiatives was made available on the company's website concurrently.
- 5The company referenced non-GAAP financial information in its presentation, with reconciliations available in the supplemental information.
- 6The 8-K provides access to key financial disclosures and strategic updates relevant to investors.
- 7All furnished exhibits are considered important for a complete understanding of BMY's Q2 2021 performance and outlook.